(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1681013

瘢痕管理市場- 世界および地域別分析：製品タイプ別、傷跡タイプ別、エンドユーザー別、国別 - 分析と予測（2025年～2035年）

Scar Management Market - A Global and Regional Analysis: Focus on Product, Scar Type, End User, and Country Analysis - Analysis and Forecast, 2025-2035
PrevNext
1
2
3
4

出版日
発行
BIS Research
ページ情報
英文 130 Pages
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
瘢痕管理市場- 世界および地域別分析：製品タイプ別、傷跡タイプ別、エンドユーザー別、国別 - 分析と予測（2025年～2035年）
出版日: 2025年03月18日
発行: BIS Research
ページ情報: 英文 130 Pages
納期: 1～5営業日
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の瘢痕管理の市場規模は、皮膚関連疾患の増加、審美的関心の高まり、皮膚科治療の進歩、外科手術の増加などを背景に、着実な成長を遂げています。

この市場には、外科手術、火傷、怪我、にきび、妊娠線などによる瘢痕を最小化、除去、改善するための様々な製品や治療法が含まれます。

さらに、規制の進展、継続的な調査、医療専門家と業界リーダーとの戦略的提携により、瘢痕治療の革新が加速しています。このような努力は、消費者のニーズを満たすように進化する世界の瘢痕管理市場の有望な軌道を反映しています。認知度の向上、技術の進歩、多様な治療オプションの利用可能性は、今後数年間における瘢痕管理市場の変革をさらに促進すると予想されます。

製品別では、シリコーンゲルおよびスプレーが、臨床的有効性が証明されていること、塗布が容易であること、広く入手可能であることから、世界の瘢痕管理市場において独占的なセグメントとなっています。これらの製品は、肥厚性瘢痕、ケロイド、術後瘢痕の管理に皮膚科医や形成外科医から広く推奨されています。しかし、シリコンスカラードレッシングはさらに市場の成長を加速させると予想されます。

萎縮性瘢痕は、主にニキビ跡の高い有病率、美意識の高まり、皮膚科治療の進歩により、世界の瘢痕管理市場を独占しています。萎縮性瘢痕は、くぼんだり陥没したりした皮膚痕として現れるもので、一般にニキビ、水疱瘡、外傷、手術などが原因で生じ、最も広く治療されている瘢痕のひとつです。若年成人の85％近くがにきびに罹患していることから、多くの人が効果的な瘢痕管理ソリューションを求めており、局所治療、レーザー治療、マイクロニードル治療、ケミカルピーリング、皮膚充填剤の需要を促進しています。

世界の瘢痕管理市場を独占しているのは病院セグメントであり、その主な理由は、外科手術や熱傷治療の件数が多いこと、そして高度な瘢痕管理ソリューションを利用できることです。病院は、手術後の瘢痕治療、外傷管理、特殊な皮膚科治療の主要なセンターとして機能しており、最大のエンドユーザーセグメントとなっています。手術、重度の熱傷治療、再建術を受ける患者は、シリコーンドレッシング、レーザー治療、コルチコステロイド注射、皮膚移植などの医療グレードの瘢痕治療を必要とすることが多く、これらは病院環境で広く利用されています。

2024年には北米地域が世界の瘢痕管理市場を独占していましたが、2025年～2035年の予測期間中にはアジア太平洋が最も高いCAGRを記録すると予想されます。北米は世界の瘢痕管理市場において支配的な地位を占めていますが、その主な理由は高度なヘルスケアインフラ、高い美容意識、手術件数の増加です。米国とカナダがこの地域をリードしており、術後の瘢痕管理を必要とする手術を含む美容整形手術や再建手術の需要の高まりがその要因となっています。

当レポートでは、世界の瘢痕管理市場について調査し、市場の概要とともに、シーケンシングタイプ別、製品別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 世界の瘢痕管理市場：業界展望

  • 市場概要
  • 主な動向
  • サプライチェーン分析
  • 購入チャネル
  • 償還シナリオ
  • 規制状況

第2章 世界の瘢痕管理市場：市場力学

    • 影響分析
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第3章 世界の瘢痕管理市場分析（製品別）、100万米ドル、2024年～2035年

  • 概要
  • シリコンジェルとスプレー
  • シリコンドレッシング
  • クリームと軟膏
  • その他

第4章 世界の瘢痕管理市場分析（傷跡タイプ別）、100万米ドル、2024年～2035年

  • 概要
  • 萎縮性瘢痕
  • 肥厚性瘢痕とケロイド瘢痕
  • その他

第5章 世界の瘢痕管理市場分析（エンドユーザー別）、100万米ドル、2024年～2035年

  • 病院
  • 専門クリニック
  • 在宅ヘルスケア

第6章 世界の瘢痕管理市場分析（地域別）、100万米ドル、2024年～2035年

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第7章 世界の瘢痕管理市場-競合ベンチマーキングと企業プロファイル

  • 競合ベンチマーキング
  • 競合情勢
    • 各社の主な戦略と展開
    • 主な発展分析
  • 企業プロファイル
    • Advancis Medical
    • Bayer AG
    • B. Braun SE
    • Bio Med Sciences, Inc.
    • Covalon Technologies Ltd.
    • Derma E
    • Molnlycke Health Care AB
    • Newmedical Technology Inc
    • Quantum Health
    • Sonoma Pharmaceuticals, Inc
    • Stratpharma AG.
    • Scar Heal, Inc
    • Weigao Group.
    • Winner Medical Co., Ltd.

第8章 調査手法

目次
Product Code: BHM1435SB

Global Scar Management Market: Industry Overview

The global scar management market is experiencing steady growth, driven by rising incidences of skin-related conditions, increasing aesthetic concerns, advancements in dermatological treatments, and a growing number of surgical procedures. The market includes various products and treatments designed to minimize, eliminate, or improve the appearance of scars caused by surgical procedures, burns, injuries, acne, and stretch marks.

Additionally, regulatory advancements, continuous research, and strategic collaborations between medical professionals and industry leaders are accelerating innovation in scar treatment. These efforts reflect a promising trajectory for the global scar management market as it evolves to meet consumer needs. Increasing awareness, technological advancements, and the availability of diverse treatment options are expected to further drive scar management market transformation in the coming years.

Market Segmentation:

Segmentation 1: by Product

  • Silicone gel and spray
  • Silicone Dressing
  • Cream and Ointments
  • Others

Silicone Gel and Spray to Continue its Dominance in the Product Segment

Based on product, silicone gels and sprays, have emerged as the dominant segment in the global scar management market due to their proven clinical efficacy, ease of application, and widespread availability. These products are widely recommended by dermatologists and plastic surgeons for managing hypertrophic scars, keloids, and post-surgical scars. However, silicone scar dressing is further expected to accelerate the market growth.

Segmentation 2: by Scar Type

  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Others

Atrophic Scars to Continue its Dominance in the Scar Type Segment

The atrophic scars segment dominates the global scar management market, primarily due to the high prevalence of acne scars, rising aesthetic consciousness, and advancements in dermatological treatments. Atrophic scars, which appear as depressed or sunken skin marks, commonly result from acne, chickenpox, trauma, or surgery, making them one of the most widely treated scar types. With acne affecting nearly 85% of young adults, a significant number of individuals seek effective scar management solutions, fuelling demand for topical treatments, laser therapy, microneedling, chemical peels, and dermal fillers.

Segmentation 3: by End User

  • Hospitals
  • Specialty Clinics
  • Home Healthcare

Hospitals to Continue its Dominance in the End User Segment

The hospital segment dominates the global scar management market, primarily due to the high volume of surgical procedures, burn treatments, and access to advanced scar management solutions. Hospitals serve as the primary centers for post-surgical scar care, trauma management, and specialized dermatological treatments, making them the largest end-user segment. Patients undergoing surgeries, severe burn treatments, and reconstructive procedures often require medical-grade scar therapies, including silicone dressings, laser treatments, corticosteroid injections, and skin grafting, which are widely available in hospital settings.

Segmentation 5: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Ireland
    • Belgium
    • Portugal
    • Netherlands
    • Switzerland
    • Finland
    • Czech Republic
    • Norway
    • Denmark
    • Sweden
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Singapore
    • South Korea
    • Thailand
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Rest-of-Latin America
  • Rest-of-the-World

In 2024, the North America region dominated the global scar management market; however, the Asia-Pacific region is expected to register the highest CAGR during the forecast period 2025-2035. North America holds the dominant position in the global scar management market, primarily due to its advanced healthcare infrastructure, high aesthetic awareness, and increasing number of surgical procedures. The U.S. and Canada lead the region, driven by rising demand for cosmetic and reconstructive surgeries, including procedures that require post-surgical scar management.

Recent Developments in the Global Scar Management Market

  • In October 2022, Foshan United Medical Technologies Ltd. collaborated with both business and regulatory bodies to develop standardized product norms for silicone scar gel products. The culmination of this effort resulted in the creation of a scientific paper titled "The Evaluation and its Method on Moisture Retention of Silicone Scar Gel."
  • In August 2021, Merz Therapeutics and Acino signed a distribution agreement in Ukraine, CIS, and Mongolia. Acino would be responsible for commercializing Merz Therapeutics' product portfolio, covering areas such as hepatic encephalopathy, Parkinson's disease, scar, and hair treatment.
  • In September 2021, Sonoma Pharmaceuticals, Inc. launched three innovative products for consumers. These products, namely, Regenacyn advanced scar gel, Ocucyn eyelid, and eyelash cleanser, were made available for purchase without a prescription, making them easily accessible to consumers.

Demand - Drivers, Restraints and Opportunities

Market Demand Drivers:

  • Rising Incidence of Burn and Trauma Injuries: The increasing incidence of burn and trauma injuries is a significant driver of the scar management market, as these injuries often result in severe scarring that requires specialized treatment. Burns, whether caused by fire, chemicals, radiation, or electrical exposure, can lead to hypertrophic and contracture scars, which can impact mobility, functionality, and aesthetic appearance. Similarly, traumatic injuries from road accidents, workplace incidents, and violence-related wounds frequently cause deep tissue damage, necessitating advanced scar management solutions to enhance healing and minimize long-term skin damage. According to the World Health Organization (WHO), burns cause approximately 180,000 deaths annually, with a significant proportion of survivors experiencing permanent scarring and disfigurement.
  • Increasing Concern Among People Regarding their Aesthetic Appearance: The increasing concern for aesthetic appearance is a key factor fuelling the growth of the scar management market, as individuals seek effective solutions to reduce or eliminate visible scars caused by acne, surgeries, injuries, burns, and stretch marks. In today's image-conscious society, the rising influence of social media, beauty standards, and self-confidence awareness has led more people to explore advanced scar treatments to improve their skin's appearance.

Market Restraints:

  • High Procedural Costs Associated with Scar Treatments and Management Solutions: The high procedural costs associated with scar treatments and management solutions present a significant challenge to the growth of the scar management market, limiting access to advanced and effective treatment options for many patients. While technological advancements have led to the development of innovative scar management solutions, such as laser therapy, microneedling, platelet-rich plasma (PRP) therapy, and stem cell-based treatments, these procedures often come with high price tags, making them inaccessible to a large segment of the population.

Market Opportunities:

  • Emergence of Remote Monitoring and Digital Health Solutions: Advances in technology and ongoing research and development efforts offer the potential for innovative and more efficient solutions to emerge, creating opportunities for companies to differentiate themselves. These advancements can further contribute to the overall growth of the scar management market.

How can this report add value to an organization?

Workflow/Innovation Strategy: The scar management market (by scar type) comprises atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. Moreover, the study provides the reader with a detailed understanding of the various types of scars and associated products tailored to address these scars.

Growth/Marketing Strategy: The scar management market's growth strategy includes innovation, expansion into emerging markets, collaboration with healthcare professionals, and regulatory streamlining. These efforts aim to enhance accessibility and meet the diverse needs of consumers.

Competitive Strategy: Key players in the global scar management market have been analyzed and profiled in the study, including new product launches and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global scar management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the scar management market size is 2024. The historical year analysis has been done from FY2021 to FY2023, and the market size has been calculated for FY2024 and projected for the period 2025-2035.
  • The geographical distribution of the market revenue is estimated to be the same as the company's net revenue distribution. All the numbers are adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR is calculated from 2025 to 2035.
  • The market has been mapped based on different types of products available in the market and based on several indications. All the key manufacturing companies that have a significant number of offerings to the long-acting drug delivery technologies and services market have been considered and profiled in the report.
  • In the study, the primary respondent's verification has been considered to finalize the estimated market for the long-acting drug delivery technologies and services market.
  • The latest annual reports of each market player have been taken into consideration for market revenue calculation.
  • The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website.

Primary Research

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding of the numbers of the various markets for market type
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), International Society for Dermatology (ISD), American Academy of Dermatology (AAD), International Association for Scar Management (IASM), and European Dermatology Forum (EDF), and among others.
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their portfolio
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentations, split-ups, and percentage shares
  • Data for market value
  • Key industry trends of the top players in the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The global scar management market is witnessing substantial growth, driven by rising awareness of scar-related concerns, advancements in medical technologies, and increasing demand for aesthetics and treatments. The scar management market encompasses a diverse range of products aimed at improving both the appearance and functionality of scars resulting from injuries, surgeries, burns, and medical conditions. Among the widely used solutions, silicone sheets, scar gels, creams, and ointments stand out as popular over-the-counter (OTC) scar management products, offering convenience and self-administration options.

The expansion of the scar management market is fuelled by factors such as the rising incidence of burn injuries, an increasing number of surgical procedures, and a growing prevalence of traumatic injuries, all of which contribute to the demand for effective scar treatment solutions. The scar management market is segmented into various categories, including product type, scar type, and end users, reflecting the growing diversification in treatment options and consumer preferences. As innovations continue to shape the scar management market, emerging technologies and professional treatments are expected to further drive its evolution and accessibility.

Some of the prominent companies in the scar management market are:

  • Bayer AG
  • B. Braun SE
  • Advancis Medical
  • Molnlycke Health Care AB
  • Winner Medical Co., Ltd.
  • Weigao Group
  • Bio Med Sciences
  • Sonoma Pharmaceuticals, Inc.
  • Covalon Technologies Ltd.
  • Stratpharma Switzerland
  • Derma E
  • Newmedical Technology Inc.
  • Quantum Health

Companies that are not a part of the aforementioned pool have been well-represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope of the Study

Market/Product Definition

Inclusion and Exclusion Criteria

1. Global Scar Management Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
  • 1.3 Supply Chain Analysis
  • 1.4 Purchasing Channels
  • 1.5 Reimbursement Scenario
  • 1.6 Regulatory Landscape

2. Global Scar Management Market: Market Dynamics

    • 2.1.1 Impact Analysis
    • 2.1.2 Market Drivers
    • 2.1.3 Market Restraints
    • 2.1.4 Market Opportunities

3. Global Scar Management Market Analysis (By Product), $Million, 2024-2035

  • 3.1 Overview
  • 3.2 Silicon Gel and Spray
  • 3.3 Silicon Dressings
  • 3.4 Cream and Ointments
  • 3.5 Others

4. Global Scar Management Market Analysis (By Scar Type), $Million, 2024-2035

  • 4.1 Overview
  • 4.2 Atrophic Scars
  • 4.3 Hypertrophic and Keloid Scars
  • 4.4 Others

5. Global Scar Management Market Analysis (By End User), $Million, 2024-2035

  • 5.1 Hospitals
  • 5.2 Specialty Clinics
  • 5.3 Home Healthcare

6. Global Scar Management Market Analysis (By Region), $Million, 2024-2035

  • 6.1 North America
    • 6.1.1 Market Dynamics
    • 6.1.2 Market Sizing and Forecast
      • 6.1.2.1 By Product
      • 6.1.2.2 By Scar Type
      • 6.1.2.3 By End User
      • 6.1.2.4 By Country
        • 6.1.2.4.1 U.S.
          • 6.1.2.4.1.1 Market Dynamics
          • 6.1.2.4.1.2 Market Sizing and Forecast
          • 6.1.2.4.1.2.1 U.S. Scar Management Market, by Product
        • 6.1.2.4.2 Canada
          • 6.1.2.4.2.1 Market Dynamics
          • 6.1.2.4.2.2 Market Sizing and Forecast
          • 6.1.2.4.2.2.1 Canada Scar Management Market, by Product
  • 6.2 Europe
    • 6.2.1 Market Dynamics
    • 6.2.2 Market Sizing and Forecast
      • 6.2.2.1 By Product
      • 6.2.2.2 By Scar Type
      • 6.2.2.3 By End User
      • 6.2.2.4 By Country
        • 6.2.2.4.1 U.K.
          • 6.2.2.4.1.1 Market Dynamics
          • 6.2.2.4.1.2 Market Sizing and Forecast
          • 6.2.2.4.1.2.1 U.K. Scar Management Market, by Product
        • 6.2.2.4.2 Germany
          • 6.2.2.4.2.1 Market Dynamics
          • 6.2.2.4.2.2 Market Sizing and Forecast
          • 6.2.2.4.2.2.1 Germany Scar Management Market, by Product
        • 6.2.2.4.3 France
          • 6.2.2.4.3.1 Market Dynamics
          • 6.2.2.4.3.2 Market Sizing and Forecast
          • 6.2.2.4.3.2.1 France Scar Management Market, by Product
        • 6.2.2.4.4 Italy
          • 6.2.2.4.4.1 Market Dynamics
          • 6.2.2.4.4.2 Market Sizing and Forecast
          • 6.2.2.4.4.2.1 Italy Scar Management Market, by Product
        • 6.2.2.4.5 Spain
          • 6.2.2.4.5.1 Market Dynamics
          • 6.2.2.4.5.2 Market Sizing and Forecast
          • 6.2.2.4.5.2.1 Spain Scar Management Market, by Product
        • 6.2.2.4.6 Russia
          • 6.2.2.4.6.1 Market Dynamics
          • 6.2.2.4.6.2 Market Sizing and Forecast
          • 6.2.2.4.6.2.1 Russia Scar Management Market, by Product
        • 6.2.2.4.7 Ireland
          • 6.2.2.4.7.1 Market Dynamics
          • 6.2.2.4.7.2 Market Sizing and Forecast
          • 6.2.2.4.7.2.1 Ireland Scar Management Market, by Product
        • 6.2.2.4.8 Belgium
          • 6.2.2.4.8.1 Market Dynamics
          • 6.2.2.4.8.2 Market Sizing and Forecast
          • 6.2.2.4.8.2.1 Belgium Scar Management Market, by Product
        • 6.2.2.4.9 Portugal
          • 6.2.2.4.9.1 Market Dynamics
          • 6.2.2.4.9.2 Market Sizing and Forecast
          • 6.2.2.4.9.2.1 Portugal Scar Management Market, by Product
        • 6.2.2.4.10 Netherlands
          • 6.2.2.4.10.1 Market Dynamics
          • 6.2.2.4.10.2 Market Sizing and Forecast
          • 6.2.2.4.10.2.1 Netherlands Scar Management Market, by Product
        • 6.2.2.4.11 Switzerland
          • 6.2.2.4.11.1 Market Dynamics
          • 6.2.2.4.11.2 Market Sizing and Forecast
          • 6.2.2.4.11.2.1 Switzerland Scar Management Market, by Product
        • 6.2.2.4.12 Norway
          • 6.2.2.4.12.1 Market Dynamics
          • 6.2.2.4.12.2 Market Sizing and Forecast
          • 6.2.2.4.12.2.1 Norway Scar Management Market, by Product
        • 6.2.2.4.13 Denmark
          • 6.2.2.4.13.1 Market Dynamics
          • 6.2.2.4.13.2 Market Sizing and Forecast
          • 6.2.2.4.13.2.1 Denmark Scar Management Market, by Product
        • 6.2.2.4.14 Sweden
          • 6.2.2.4.14.1 Market Dynamics
          • 6.2.2.4.14.2 Market Sizing and Forecast
          • 6.2.2.4.14.2.1 Sweden Scar Management Market, by Product
        • 6.2.2.4.15 Czech Republic
          • 6.2.2.4.15.1 Market Dynamics
          • 6.2.2.4.15.2 Market Sizing and Forecast
          • 6.2.2.4.15.2.1 Czech Republic Scar Management Market, by Product
        • 6.2.2.4.16 Finland
          • 6.2.2.4.16.1 Market Dynamics
          • 6.2.2.4.16.2 Market Sizing and Forecast
          • 6.2.2.4.16.2.1 Finland Scar Management Market, by Product
        • 6.2.2.4.17 Rest of Europe
          • 6.2.2.4.17.1 Market Dynamics
          • 6.2.2.4.17.2 Market Sizing and Forecast
          • 6.2.2.4.17.2.1 Rest of Europe Scar Management Market, by Product
  • 6.3 Asia Pacific
    • 6.3.1 Market Dynamics
    • 6.3.2 Market Sizing and Forecast
      • 6.3.2.1 By Product
      • 6.3.2.2 By Scar Type
      • 6.3.2.3 By End User
      • 6.3.2.4 By Country
        • 6.3.2.4.1 Japan
          • 6.3.2.4.1.1 Market Dynamics
          • 6.3.2.4.1.2 Market Sizing and Forecast
          • 6.3.2.4.1.2.1 Japan Scar Management Market, by Product
        • 6.3.2.4.2 China
          • 6.3.2.4.2.1 Market Dynamics
          • 6.3.2.4.2.2 Market Sizing and Forecast
          • 6.3.2.4.2.2.1 China Scar Management Market, by Product
        • 6.3.2.4.3 India
          • 6.3.2.4.3.1 Market Dynamics
          • 6.3.2.4.3.2 Market Sizing and Forecast
          • 6.3.2.4.3.2.1 India Scar Management Market, by Product
        • 6.3.2.4.4 Australia
          • 6.3.2.4.4.1 Market Dynamics
          • 6.3.2.4.4.2 Market Sizing and Forecast
          • 6.3.2.4.4.2.1 Australia Scar Management Market, by Product
        • 6.3.2.4.5 Singapore
          • 6.3.2.4.5.1 Market Dynamics
          • 6.3.2.4.5.2 Market Sizing and Forecast
          • 6.3.2.4.5.2.1 Singapore Scar Management Market, by Product
        • 6.3.2.4.6 South Korea
          • 6.3.2.4.6.1 Market Dynamics
          • 6.3.2.4.6.2 Market Sizing and Forecast
          • 6.3.2.4.6.2.1 South Korea Scar Management Market, by Product
        • 6.3.2.4.7 Thailand
          • 6.3.2.4.7.1 Market Dynamics
          • 6.3.2.4.7.2 Market Sizing and Forecast
          • 6.3.2.4.7.2.1 Singapore Scar Management Market, by Product
        • 6.3.2.4.8 Rest-of -Asia-Pacific
          • 6.3.2.4.8.1 Market Dynamics
          • 6.3.2.4.8.2 Market Sizing and Forecast
          • 6.3.2.4.8.2.1 Rest-of-Asia-Pacific Scar Management Market, by Product
  • 6.4 Latin America
    • 6.4.1 Market Dynamics
    • 6.4.2 Market Sizing and Forecast
      • 6.4.2.1 By Product
      • 6.4.2.2 By Scar Type
      • 6.4.2.3 By End User
      • 6.4.2.4 By Country
        • 6.4.2.4.1 Brazil
          • 6.4.2.4.1.1 Market Dynamics
          • 6.4.2.4.1.2 Market Sizing and Forecast
          • 6.4.2.4.1.2.1 Brazil Scar Management Market, by Product
        • 6.4.2.4.2 Mexico
          • 6.4.2.4.2.1 Market Dynamics
          • 6.4.2.4.2.2 Market Sizing and Forecast
          • 6.4.2.4.2.2.1 Mexico Scar Management Market, by Product
        • 6.4.2.4.3 Argentina
          • 6.4.2.4.3.1 Market Dynamics
          • 6.4.2.4.3.2 Market Sizing and Forecast
          • 6.4.2.4.3.2.1 Argentina Scar Management Market, by Product
        • 6.4.2.4.4 Chile
          • 6.4.2.4.4.1 Market Dynamics
          • 6.4.2.4.4.2 Market Sizing and Forecast
          • 6.4.2.4.4.2.1 Chile Scar Management Market, by Product
        • 6.4.2.4.5 Rest-of-Latin America
          • 6.4.2.4.5.1 Market Dynamics
          • 6.4.2.4.5.2 Market Sizing and Forecast
          • 6.4.2.4.5.2.1 Rest-of -Latin America Scar Management Market, by Product
  • 6.5 Rest-of-the-World
    • 6.5.1 Market Dynamics
    • 6.5.2 Market Sizing and Forecast
      • 6.5.2.1 By Product
      • 6.5.2.2 By Scar Type
      • 6.5.2.3 By End User
      • 6.5.2.4 By Country

7. Global Scar Management Market - Competitive Benchmarking and Company Profiles

  • 7.1 Competitive Benchmarking
  • 7.2 Competitive Landscape
    • 7.2.1 Key Strategies and Developments by Company
      • 7.2.1.1 Funding Activities
      • 7.2.1.2 Mergers and Acquisitions
      • 7.2.1.3 Regulatory Approvals
      • 7.2.1.4 Partnerships, Collaborations, and Business Expansions
    • 7.2.2 Key Developments Analysis
  • 7.3 Company Profiles
    • 7.3.1 Advancis Medical
    • 7.3.2 Bayer AG
    • 7.3.3 B. Braun SE
    • 7.3.4 Bio Med Sciences, Inc.
    • 7.3.5 Covalon Technologies Ltd.
    • 7.3.6 Derma E
    • 7.3.7 Molnlycke Health Care AB
    • 7.3.8 Newmedical Technology Inc
    • 7.3.9 Quantum Health
    • 7.3.10 Sonoma Pharmaceuticals, Inc
    • 7.3.11 Stratpharma AG.
    • 7.3.12 Scar Heal, Inc
    • 7.3.13 Weigao Group.
    • 7.3.14 Winner Medical Co., Ltd.

8. Research Methodology